Form 4: Aethlon Medical Director Sells Shares to Cover Tax Obligations

Sentiment:

SEC Form 4 Filing


Director Nicolas Gikakis sold 1,954 shares of Aethlon Medical Inc. to cover tax obligations arising from the vesting of restricted stock units.

Summary

  • On March 29, 2024, Nicolas Gikakis, a director of Aethlon Medical Inc. (AEMD), disposed of 1,954 shares of common stock.
  • The transaction was executed to cover tax withholding obligations related to the vesting of restricted stock units (RSUs) dated April 28, 2023.
  • The shares were sold at a price of $1.68 per share.
  • Following the transaction, Gikakis directly owns 13,680 shares of Aethlon Medical Inc.

Sentiment

Score: 5

Explanation: The document describes a routine transaction (tax-related share sale) and doesn't inherently indicate positive or negative sentiment.

Industry Context

Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives and directors.

Stakeholder Impact

  • The sale of shares by a director could have a minor, temporary impact on shareholder sentiment.

Key Dates

DateDescription
04/28/2023Date of the restricted stock unit (RSU) grant that triggered the tax obligation.
03/29/2024Date of the share sale transaction.

Keywords

Aethlon Medical, AEMD, Form 4, Nicolas Gikakis, Director, Share Sale, Tax Withholding, RSU, Restricted Stock Units

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.